Physician

David T Cragun, MD

According to 2025 Medicare claims, David Cragun, MD (NPI: 1821005349) practices interventional cardiology in the Provo-Orem-Lehi, UT market, with the plurality of this provider's patient population coming from Utah, UT. This provider's primary affiliated billing organization is REVERE HEALTH PC (NPI: 1093764805; TIN: 870281028) and primary practice location at 84604-3305. Cragun is affiliated with the Aledade 201 National MSSP (ACO ID: A5522) and Castell Accountable Care, LLC (ACO ID: D0136), participating under both the MSSP and REACH models.

Cragun's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,516 traditional Medicare patients, billed 5,582 HCPCS/CPT codes, and received $472,827 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 6,738 prescription claims across 1,163 beneficiaries totaling $1,767,745 in drug costs, led by Eliquis (Apixaban). DME data shows 45 claims. Open Payments data shows 83 records totaling $1,300. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $569,900 to $1,767,745. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $27,664 to $4,318.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,586	7,303	$420,853
2016	2,390	6,767	$411,394
2017	2,189	6,579	$385,895
2018	1,978	6,492	$366,017
2019	2,396	6,930	$425,377
2020	1,764	5,943	$419,968
2021	1,688	6,011	$582,342
2022	1,566	5,867	$494,381
2023	1,488	6,576	$502,651
2024	1,516	5,582	$472,827

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	1,076	7,569	$569,900
2016	1,110	8,014	$543,873
2017	1,058	7,406	$676,656
2018	1,052	7,001	$778,009
2019	1,050	6,606	$1,057,421
2020	1,040	6,447	$1,151,074
2021	1,075	6,580	$882,472
2022	1,129	6,683	$1,097,308
2023	1,069	5,959	$1,323,127
2024	1,163	6,738	$1,767,745

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	24	227	$24,617
2016	35	222	$14,317
2017	15	155	$6,605
2018	15	143	$6,425
2019	13	96	$4,352
2020	11	111	$7,045
2021	11	156	$9,366
2022	N/R	80	$4,588
2023	N/R	97	$7,056
2024	N/R	45	$3,892

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	486	744	$86
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	686	723	$74
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	466	639	$12
93018	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician	141	142	$10
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	172	221	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	558	29,912	$576,831
Camzyos	Mavacamten	32	960	$271,602
Opsumit	Macitentan	19	570	$241,483
Adempas	Riociguat	13	390	$185,596
Entresto	Sacubitril/Valsartan	93	5,854	$110,574

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	45	$3,892

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	83	$1,300	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for David T. Cragun, MD?

Tedicare shows public-source Medicare data for David T. Cragun, MD (NPI 1821005349), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David T. Cragun, MD have ACO affiliation data?

David T. Cragun, MD is shown with ACO affiliation data for Aledade 201 National MSSP (MSSP, ACO ID A5522) and Castell Accountable Care, LLC (REACH, ACO ID D0136).

What billing organization is linked to David T. Cragun, MD?

David T. Cragun, MD is linked to REVERE HEALTH PC (billing NPI 1093764805) in the available physician profile data.

Does David T. Cragun, MD have Open Payments data?

David T. Cragun, MD has 83 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.